Literature DB >> 2680936

Management of severe malarial infection.

S Krishna, N J White.   

Abstract

Severe malaria is a major cause of infant and childhood death in the tropics. Effective management relies on rapid diagnosis, prompt administration of parenteral schizonticidal antimalarial drugs, careful fluid balance, prevention of convulsions and early recognition of complications such as hypoglycemia, metabolic acidosis, anemia, pulmonary edema, renal failure, bleeding and supervening bacterial sepsis. The mortality of treated cerebral malaria remains 20%. New, more rapidly acting antimalarials and earlier referral of children with complicated infections should reduce this unacceptable death rate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680936     DOI: 10.1007/bf02726598

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

1.  Clinical management of chloroquine-resistant Plasmodium falciparum malaria in Southeast Asia.

Authors:  N J White; D A Warrell
Journal:  Trop Doct       Date:  1983-10       Impact factor: 0.731

Review 2.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

3.  Parenteral chloroquine for treating falciparum malaria.

Authors:  N J White; G Watt; Y Bergqvist; E K Njelesani
Journal:  J Infect Dis       Date:  1987-02       Impact factor: 5.226

4.  Quinine loading dose in cerebral malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; M J Warrell; P Chanthavanich; D Bunnag; T Harinasuta
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

5.  Severe hypoglycemia and hyperinsulinemia in falciparum malaria.

Authors:  N J White; D A Warrell; P Chanthavanich; S Looareesuwan; M J Warrell; S Krishna; D H Williamson; R C Turner
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

6.  Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies.

Authors:  R E Phillips; D A Warrell; N J White; S Looareesuwan; J Karbwang
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

7.  Pharmacokinetics of quinine in children.

Authors:  F Shann; J Stace; M Edstein
Journal:  J Pediatr       Date:  1985-03       Impact factor: 4.406

8.  Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients.

Authors:  D A Warrell; S Looareesuwan; M J Warrell; P Kasemsarn; R Intaraprasert; D Bunnag; T Harinasuta
Journal:  N Engl J Med       Date:  1982-02-11       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.